The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[5-Eth-(Z)-ylidene-5H-dibenzo[a,d]cyclohepten-10-yl]-4-methyl-piperazine ID: ALA90977
PubChem CID: 44323890
Max Phase: Preclinical
Molecular Formula: C22H24N2
Molecular Weight: 316.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C/C=C1/c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21
Standard InChI: InChI=1S/C22H24N2/c1-3-18-19-9-5-4-8-17(19)16-22(21-11-7-6-10-20(18)21)24-14-12-23(2)13-15-24/h3-11,16H,12-15H2,1-2H3/b18-3-
Standard InChI Key: DISSGPVGANAWAA-ZUWFHJRGSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
4.2917 -1.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8875 -0.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4750 -1.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8042 -1.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6250 -0.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5917 -2.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1417 -0.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9625 -1.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2000 -4.1167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8875 0.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4167 -2.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0792 -3.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3792 -3.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7167 -3.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2292 0.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6042 -1.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5417 0.1958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1792 -1.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5042 -4.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 1.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2042 -0.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0250 -0.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7542 -0.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5667 -0.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 1 2 0
4 1 1 0
5 4 2 0
6 1 1 0
7 8 1 0
8 3 1 0
9 13 1 0
10 2 2 0
11 6 1 0
12 6 1 0
13 12 1 0
14 11 1 0
15 5 1 0
16 4 1 0
17 7 2 0
18 8 2 0
19 9 1 0
20 10 1 0
21 16 2 0
22 21 1 0
23 24 2 0
24 18 1 0
9 14 1 0
7 2 1 0
22 15 2 0
23 17 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 316.45Molecular Weight (Monoisotopic): 316.1939AlogP: 4.20#Rotatable Bonds: 1Polar Surface Area: 6.48Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.63CX LogP: 4.17CX LogD: 3.74Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: 0.07
References 1. Phillips ST, de Paulis T, Baron BM, Siegel BW, Seeman P, Van Tol HH, Guan HC, Smith HE.. (1994) Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors., 37 (17): [PMID:8064797 ] [10.1021/jm00043a008 ]